cgp 12177 has been researched along with Experimental Neoplasms in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Staehelin, M | 1 |
| Hertel, C | 1 |
1 other study available for cgp 12177 and Experimental Neoplasms
| Article | Year |
|---|---|
[3H]CGP-12177, a beta-adrenergic ligand suitable for measuring cell surface receptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cell Membrane; Cells, Cultured; Glio | 1983 |